However, the increase of CRIP1 level in sarcoma patients is very important for predicting the good outcome of patients, and the infiltration of activated B cells, NK cells and Th1 cells in the immune microenvironment is also related to the improvement of prognosis, suggesting that sarcoma patients with high CRIP1 expression may enhance the anti-tumor immune response of tumors. Here, CRIP1 is linked to sarcoma.